Aktie A3DE6A SHARPS TECHNOLOGY, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sharps Technology, Inc.

Aktien

A3DE6A

US82003F1012

STSS

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 31.05.2024 		% 5 Tage % 1. Jan.
0,382 USD -20,08 % Intraday Chart für Sharps Technology, Inc. +78,25 % -8,15 %
30.05. Sharps Technology unterzeichnet einen 5-Jahres-Vertriebsvertrag für Spritzen im Wert von $200 Millionen und eine Ergänzung zum Asset Purchase Agreement, um mit der Produktion von vorfüllbaren Spezial-Copolymer-Spritzen in den USA zu beginnen CI
14.05. Sharps Technology, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S
Sharps Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Sharps Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia
Sharps Technology Planning to Collaborate with Roncadelle to Support Global Distribution and Sales of High Quality, Innovative, Safer Drug Delivery Systems
Sharps Technology Signs LoI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
Sharps Technology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Sharps Technology Launches $5.6 Million Registered Direct Offering
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals
Sharps Technology Files $200 Million Mixed Shelf
Sharps Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Sharps Technology Appoints Ben Scheu as Senior Director of Sales
Sharps Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Top Premarket Gainers
Sharps Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Sharps Technology, Inc. Auditor Raises 'Going Concern' Doubt
Sharps Technology To Raise $3.8 Million Through At-The-Market Private Placement
Sharps Technology, Inc. Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization
Sharps Technology Inc. to Introduces New Specialized Prefillable Syringe Systems in 2023
Sharps Technology, Inc Begins Manufacturing At Its Hungary Facility for the Company's Innovative Syringe Products
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DE6A Aktie
  4. Nachrichten Sharps Technology, Inc.
  5. Andere Sprachen